Kolon Life Science Inc. (102940)
Market Closed
15 Oct, 06:30 AM
KRX SM KRX SM Primary ₩
12,380. 00
-600
-4.6225%
₩
655.95B Market Cap
- P/E Ratio
- Div Yield
137,234 Volume
- Eps
₩ 12,980
Previous Close Want to track 102940 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Kolon Life Science Inc. (102940) Statistics
Valuation metrics
Market Cap 655.95B
Enterprise value 313.18B
Trailing P/E (ttm) 5.19
Forward P/E -
PEG ratio 0.01
Price/Sales (ttm) 0.88
Price/Book (mrq) 0.27
Enterprise Value/Revenue 1.48
Enterprise Value/EBITDA 8.68
Overview
Shares outstanding 11.41M
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 64.68K
Average volume (90 days) 173.64K
Price summary
52-Week low 12,030
52-Week high 72,700
Beta -
50-Day moving average 14,570.31
200-Day moving average 37,146.64
Dividends and splits
Forward annual dividend rate 533.33
Forward annual dividend yield 0.0098%
Trailing annual dividend rate 133.33
Trailing annual dividend yield 0.0025%
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:1
Last split Date 27 Dec 2017
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin 0.16%
Operating margin 0.17%
Operational effectiveness
Return on assets 0.03%
Return on equity 0.06%
Income Statement
Revenue (ttm) 208.98B
Revenue per share (ttm) 16,151.46
Quarterly revenue growth (yoy) 0.11%
Gross profit (ttm) 55.89B
EBITDA 15.08B
Net income to common (ttm) 24.96B
Diluted EPS (ttm) 2,645.19
Quarterly earnings growth (yoy) 0.11%
Balance Sheet
Total cash (mrq) 10.64B
Total cash per share (mrq) 2,421.17
Total debt (mrq) 103.73B
Total Debt/Equity (mrq) 0.23
Current ratio (mrq) 0.76%
Book value per share (mrq) 53,237
Cash Flow
Cash flow statement 1.24B
Levered free cash flow (LFCF) 24.96B
2026 © Marketlog. All Rights Reserved.
